Unani Modality(Bukhoor therapy) and its Efficacy in Low back pain management.

EVALUATION OF CLINICAL AND ANTI-INFLAMMATORY EFFECT OF BUKHOOR (MEDICATED STEAM ) IN THE MANAGMENT OF NON-SPECIFIC LOW BACK PAIN (WAJA’AL-ZAHR).

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046531

Enrollment

Registered

2022-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Bukhoor(steam therapy) : Bukhoor from the decoction of 2nd volume). Will be given on lumbo-sacral region according to weekly duration by using specially designed steam equipment. Dose o

Eligibility

Inclusion criteria

Inclusion criteria: ? Diagnosed patient of nonspecific low back pain. ? Patient who have agreed to sign informed consent and follow up the protocol. ? Patient who will be ready to discontinue NSAIDS or any other medications for any other conditions. ? Patient who will be having pain scale of minimum 30 mm. ? VAS score will be used to quantify pain and restriction of movement as mild, moderate and severe.

Exclusion criteria

Exclusion criteria: ? Patients below the age of 18 and above the age of 65 years. ? Pregnancy and lactations. ? Patients with systemic disorders like CRF, CLD and cardiac dysfunctions. ? Uncontrolled diabetes mellitus ? History of urticaria. ? Any skin disease on the localised area. ? Other types of Arthritis (Tubercular, infective arthritis etc). Patients who have low back pain due to specific and known etiological causes (infection, tumour, osteoporosis, ankylosing spondylitis, fracture). ?Patients who are planning for vertebra surgery. ?Patients having any psychological disorders.

Design outcomes

Primary

Measure	Time frame
Improvement in : ?Sign symptoms ?VAS ?Oswestry low back pain disability scale ?SF-12 ?Efficacy should be quantified on basis of questionnaire from SF-12 and Oswestry low back pain disability scale. ?Mobility questionnaire will be prepared from oswestry low back pain disability scale. Timepoint: 3 weeks	—

Secondary

Measure	Time frame
? Antioxidant status and oxidative stress index.Timepoint: 3 weeks	—

Countries

India

Contacts

Public Contactsafia usmanii

Department of Ilaj bit Tadbeer, Ajmal khan Tibbiya College, F/o Unani Medicine, AMU, Aligarh

aasia.sultana@gmail.com8755199034

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026